OpenAI acquires biotech startup Orchestra Bio to push into drug development
Posted On October 20, 2026
OpenAI’s acquisition could revolutionize drug development, potentially reducing timelines and increasing efficiency in the pharmaceutical industry.
The post OpenAI acquires biotech startup Orchestra Bio to push into drug development appeared first on Crypto Briefing.
About The Author
